Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ...
IW Capital has invested in Lucida Medical, a Cambridge and UK healthtech company using AI to help clinicians diagnose prostate cancer from MRI scans faster and more accurately.
– First multicenter, randomized controlled trial directly comparing a new technology to robotic RP for men with localized prostate cancer to successfully recruit to target enrollment – – TULSA ...
A scan that makes prostate cancer cells “glow” could halve the number of men needing invasive biopsies, research suggests.
Scans that make prostate cancer cells glow can eliminate the need for invasive biopsies and cut false positive—and they're ...
An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following inconclusive or reassuring results from an MRI scan, new research has found. Findings ...
Australian scientists say it could also help reduce the risk of overdiagnosis by determining which cancers are low-risk and will never cause harm. The post New state-of-the-art test identifies ...
Detailed price information for Profound Medical Corp (PROF-Q) from The Globe and Mail including charting and trades.
Seldom does a London hospital’s waiting area feel peaceful. The television hums over discussions about test results, chairs ...
Prenuvo is launching a new bloodwork component to complement its full-body MRI offerings as part of a new membership package.
Betsi Cadwaladr University Health Board’s CEO apologised 'for the unacceptable delays' ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results